Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 479

1.

Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics.

Gianfrancesco FD, Rajagopalan K, Sajatovic M, Wang RH.

J Clin Psychiatry. 2006 Feb;67(2):222-32.

PMID:
16566617
[PubMed - indexed for MEDLINE]
2.

Treatment adherence among patients with schizophrenia treated with atypical and typical antipsychotics.

Gianfrancesco FD, Rajagopalan K, Sajatovic M, Wang RH.

Psychiatry Res. 2006 Nov 15;144(2-3):177-89. Epub 2006 Sep 27.

PMID:
17010448
[PubMed - indexed for MEDLINE]
3.

Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder.

Zhu B, Kulkarni PM, Stensland MD, Ascher-Svanum H.

Curr Med Res Opin. 2007 Nov;23(11):2805-14.

PMID:
17910804
[PubMed - indexed for MEDLINE]
4.

Comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine.

Gianfrancesco F, Pesa J, Wang RH.

J Manag Care Pharm. 2005 Apr;11(3):220-30.

PMID:
15804206
[PubMed - indexed for MEDLINE]
Free Article
5.

Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder.

Hassan M, Madhavan SS, Kalsekar ID, Makela EH, Rajagopalan K, Islam S, Kavookjian J, Miller LA.

Ann Pharmacother. 2007 Nov;41(11):1812-8. Epub 2007 Oct 9.

PMID:
17925501
[PubMed - indexed for MEDLINE]
6.

Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications.

Gianfrancesco F, Rajagopalan K, Goldberg JF, Wang RH.

Bipolar Disord. 2007 May;9(3):252-61.

PMID:
17430300
[PubMed - indexed for MEDLINE]
7.

The association between treatment adherence and antipsychotic dose among individuals with bipolar disorder.

Gianfrancesco FD, Sajatovic M, Rajagopalan K, Wang RH.

Int Clin Psychopharmacol. 2008 Nov;23(6):305-16. doi: 10.1097/YIC.0b013e32830b0f88.

PMID:
18854718
[PubMed - indexed for MEDLINE]
8.

Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.

Jing Y, Kim E, You M, Pikalov A, Tran QV.

J Med Econ. 2009 Jun;12(2):104-13. doi: 10.3111/13696990903044092.

PMID:
19527195
[PubMed - indexed for MEDLINE]
9.

Association between antipsychotic combination therapy and treatment adherence among individuals with bipolar disorder.

Gianfrancesco FD, Sajatovic M, Tafesse E, Wang RH.

Ann Clin Psychiatry. 2009 Jan-Mar;21(1):3-16.

PMID:
19239828
[PubMed - indexed for MEDLINE]
10.

Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.

Moisan J, Grégoire JP.

Clin Ther. 2010;32 Suppl 1:S21-31. doi: 10.1016/j.clinthera.2010.01.003.

PMID:
20152549
[PubMed - indexed for MEDLINE]
11.

Antipsychotic treatment adherence and associated mental health care use among individuals with bipolar disorder.

Gianfrancesco FD, Sajatovic M, Rajagopalan K, Wang RH.

Clin Ther. 2008 Jul;30(7):1358-74.

PMID:
18691997
[PubMed - indexed for MEDLINE]
12.

Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.

Kim E, Maclean R, Ammerman D, Jing Y, Pikalov A, You M, Van-Tran Q, L'Italien G.

Clin Ther. 2009 Apr;31(4):836-48. doi: 10.1016/j.clinthera.2009.04.022.

PMID:
19446157
[PubMed - indexed for MEDLINE]
13.

Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.

Guo JJ, Keck PE Jr, Corey-Lisle PK, Li H, Jiang D, Jang R, L'Italien GJ.

J Clin Psychiatry. 2006 Jul;67(7):1055-61.

PMID:
16889448
[PubMed - indexed for MEDLINE]
14.

Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania.

Miller DS, Yatham LN, Lam RW.

J Clin Psychiatry. 2001 Dec;62(12):975-80.

PMID:
11780879
[PubMed - indexed for MEDLINE]
15.

Atypical antipsychotics: newer options for mania and maintenance therapy.

Vieta E, Goikolea JM.

Bipolar Disord. 2005;7 Suppl 4:21-33. Review.

PMID:
15948764
[PubMed - indexed for MEDLINE]
16.

Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.

Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Rosenheck RA, Perkins DO, Keefe RS, Davis CE, Severe J, Hsiao JK; CATIE Investigators.

Am J Psychiatry. 2006 Apr;163(4):611-22.

PMID:
16585435
[PubMed - indexed for MEDLINE]
17.

Cost analysis of the treatment of schizophrenia in Thailand: a simulation model comparing olanzapine, risperidone, quetiapine, ziprasidone and haloperidol.

Kongsakon R, Leelahanaj T, Price N, Birinyi-Strachan L, Davey P.

J Med Assoc Thai. 2005 Sep;88(9):1267-77.

PMID:
16536115
[PubMed - indexed for MEDLINE]
18.

Typical and atypical antipsychotics in bipolar depression.

Gao K, Gajwani P, Elhaj O, Calabrese JR.

J Clin Psychiatry. 2005 Nov;66(11):1376-85. Review.

PMID:
16420074
[PubMed - indexed for MEDLINE]
19.

Atypical antipsychotics in the treatment of affective symptoms: a review.

Masan PS.

Ann Clin Psychiatry. 2004 Jan-Mar;16(1):3-13. Review.

PMID:
15147108
[PubMed - indexed for MEDLINE]
20.

Adjunctive risperidone, olanzapine and quetiapine for the treatment of hospitalized patients with bipolar I disorder: a retrospective study.

Pae CU, Nassir Ghaemi S, Patkar A, Chae JH, Bahk WM, Jun TY, Masand P.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1322-5. Epub 2006 Apr 24.

PMID:
16631294
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk